Discafani, C M <br/><br/>
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785).  [electronic resource] 

 -  Biochemical pharmacology  Apr 1999 
 - 917-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-2952 
<br/><br/><label>Standard No.: </label>10.1016/s0006-2952(98)00356-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemical synthesis<br/>Cell Cycle--drug effects<br/>Cell Division--drug effects<br/>Drug Screening Assays, Antitumor<br/>Enzyme Inhibitors--chemical synthesis<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Mice<br/>Mice, Nude<br/>Models, Molecular<br/>Neoplasm Transplantation<br/>Neoplasms, Experimental--drug therapy<br/>Phosphorylation--drug effects<br/>Quinazolines--chemical synthesis<br/>Tumor Cells, Cultured